Latest Updates

The granted claims of the patent include the class of selective H3 ligands discovered by Suven and are being developed as…

Sees 14 per cent increase in revenue for the nine months ended December 31, 2014

Aim to spur sluggish growth of biotech sector

To manufacture stem cell-based treatment of complex perianal fistulas in crohn’s disease

The anti-retrovirals drugs will be manufactured in Cipla’s state-of-the-art manufacturing facilities in India, which has been…

Patients, investigators to be speakers at Annual ISCR Conference

It ensures easy use and correct positioning of eye droppers

They are designed for sensitive and high-value injectables

The visit aimed to understand the efforts USP is making in India to create standards for medicines, ensure full safety and quality…

The agreement facilitates Cipla with a front-end presence in Morocco and enables it to develop a platform for the future with…